Gilead Issues A Voluntary Nationwide Recall of Two Lots of Veklury® (Remdesivir) Due to Presence of Glass Particulates


Foster City, CA, Gilead Sciences Inc. (Nasdaq: GILD) today announced it is voluntarily recalling two lots of Veklury® (remdesivir 100 mg for injection) to the user level. Gilead Sciences Inc. received a customer complaint, confirmed by the firm’s investigation, of the presence of glass particulates. (US Food Recalls) More More

Similar stories

Moderna recalls vaccine batch after foreign substance found in CDMO-made vial—again - FiercePharma

Moderna recalls vaccine batch after foreign substance found in CDMO-made vial—again  FiercePharma

Posted on 11 April 2022 | 2:00 am | Google News

Teva recalls one lot of leukemia med after finding particulates in vial - FiercePharma

Teva recalls one lot of leukemia med after finding particulates in vial  FiercePharma

Posted on 30 March 2022 | 2:00 am | Google News

Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials - FiercePharma

Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials  FiercePharma

Posted on 6 December 2021 | 3:00 am | Google News

Copyright © 2024 LastMinuteStuff.com | Contact info